CELL MOL LIFE SCI 润色咨询

CELLULAR AND MOLECULAR LIFE SCIENCES

出版年份:1997 年文章数:4705 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:1.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:细胞生物学<br>经验分享:免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor?有这个状态没? 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]
    2023-10-16 科研小麻瓜 来自广东省

    这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?

    20

    展开20条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:细胞生物学<br>经验分享:免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor?有这个状态没? 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]
    2022-01-30 Michael scofield123

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:细胞生物学
    经验分享:免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept

    15

    展开15条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:细胞生物学<br>经验分享:免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor?有这个状态没? 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]
    2023-09-27 ms5000000478145561 来自湖北省

    偏重的研究方向:认知功能
    经验分享:9.23重新提交,到现在还是with editor,等。。。

    13

    展开13条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:细胞生物学<br>经验分享:免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor?有这个状态没? 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]
    2023-11-09 默默0606 来自北京

    偏重的研究方向:细胞生物学
    经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……

    9

    展开9条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:细胞生物学<br>经验分享:免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor?有这个状态没? 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]
    2023-07-04 野生鄢医师 来自瑞典

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:免疫
    经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。

    9

    展开9条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:细胞生物学<br>经验分享:免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor?有这个状态没? 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]
    2023-09-09 ms9000000447204416 来自阿姆斯特丹

    1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿
    2. 2023.06.22 with editor
    3. 2023.07.13 送审
    4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)
    5. 2023.08.02 收到审稿意见(大修)
    6. 2023.08.23 返修
    7. 2023.09.01 第二轮审稿
    目前20230909 还在继续等待
    这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!
    希望审稿人和编辑身体健康,万事顺心!
    对你有帮助的话麻烦点个赞。

    8

    展开8条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:细胞生物学<br>经验分享:免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor?有这个状态没? 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]
    2020-07-10 ms9000001460504456

    请问这个杂志一般多久with editor?有这个状态没? 着急

    7

    展开7条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:细胞生物学<br>经验分享:免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor?有这个状态没? 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]
    2023-12-28 ms5000000204318340 来自山东省

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:2023.9.26 Submitted to journal
    2023.9.30 With Editor
    2023.10.3 Under review
    2023.11.3 Required reviews completed
    2023.11.13 Major revision
    2023.12.25 Revision submitted to journal
    2023.12.26 With Editor
    2023.12.26 Under review
    2023.12.27 Required reviews completed
    2023.12.27 Accept

    6

    展开6条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:细胞生物学<br>经验分享:免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor?有这个状态没? 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]
    2022-08-09 ms2000000705029865

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:分子生物学;肿瘤;分子机制
    经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好

    5

    展开5条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2163073, encodeId=7d5621630e315, content=这个杂志是怎么回事,投稿近一个月还是with editor,转OA了变慢了吗?我想三月份见刊,还有没有戏,等多久催编辑部呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Mon Oct 16 14:46:32 CST 2023, time=2023-10-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1189240, encodeId=ab7e1189240af, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:细胞生物学<br>经验分享:免疫学相关 2021.07.31 submittion 2021.08.25 major revision 2021.09.30 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/14/4a063d15cc5dff0f7e3ac32dd2b4cfd7.jpg, createdBy=e44f1946179, createdName=Michael scofield123, createdTime=Sun Jan 30 00:43:03 CST 2022, time=2022-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2167682, encodeId=2f57216e6826a, content=偏重的研究方向:细胞生物学<br>经验分享:这个杂志一开始看评论很快,大概七月底投得,with editor三周,可是under review将近三个月了还是under review,这是怎么了,急啊。不知道还要多久……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hp5icltiaJTLo0VTcHpibDaN1myRIOsia0uClo6Z2CrEt7ZM0dMXHLPwEa6Q1Hc59vJyaqTQIX38UrAfrkcKPVU5gQ/132, createdBy=84602344041, createdName=默默0606, createdTime=Thu Nov 09 21:23:20 CST 2023, time=2023-11-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2156868, encodeId=2372215686814, content=1. 2023.06.19 投稿 6.20号收到邮件因格式问题返回 6.21号重新投稿 <br>2. 2023.06.22 with editor<br>3. 2023.07.13 送审<br>4. 2023.07.30 审稿意见返回编辑部 (外审用了17天,不到3周)<br>5. 2023.08.02 收到审稿意见(大修)<br>6. 2023.08.23 返修<br>7. 2023.09.01 第二轮审稿<br>目前20230909 还在继续等待<br>这个期刊挺不错的,定位也蛮好,明年转为OA,希望影响因子节节攀升!<br>希望审稿人和编辑身体健康,万事顺心!<br>对你有帮助的话麻烦点个赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230909/ab7ced1ee00e4b7293853018393bfefa/401f3842f3034101be5a5b7e2849e373.jpg, createdBy=0b845546395, createdName=ms9000000447204416, createdTime=Sat Sep 09 14:11:37 CST 2023, time=2023-09-09, status=1, ipAttribution=阿姆斯特丹), GetPortalCommentsPageByObjectIdResponse(id=802020, encodeId=33cc80202057, content=请问这个杂志一般多久with editor?有这个状态没? 着急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Fri Jul 10 09:16:17 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2177695, encodeId=422721e76958a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:2023.9.26 Submitted to journal<br>2023.9.30 With Editor<br>2023.10.3 Under review<br>2023.11.3 Required reviews completed<br>2023.11.13 Major revision<br>2023.12.25 Revision submitted to journal<br>2023.12.26 With Editor<br>2023.12.26 Under review<br>2023.12.27 Required reviews completed<br>2023.12.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09736486374, createdName=ms5000000204318340, createdTime=Thu Dec 28 09:39:53 CST 2023, time=2023-12-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1237659, encodeId=b24e123e6590b, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:分子生物学;肿瘤;分子机制<br>经验分享:欧洲老牌杂志,三天内with editor, 十天内Under review, 一个月内Minor revision,要求文章创新性比较高,数据全面且研究深入,审稿人意见比较专业,提了许多比较细的问题,总的来说还是比较难投,感觉对国人还算友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67145690565, createdName=ms2000000705029865, createdTime=Tue Aug 09 17:53:23 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101319, encodeId=7921210131983, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=671c1671088, createdName=33333333, createdTime=Fri Nov 18 13:32:06 CST 2022, time=2022-11-18, status=1, ipAttribution=)]
    2022-11-18 33333333

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤
    经验分享:等了一个月,编辑说没找到审稿人........这杂志是不是不太行

    5

    展开5条回复
共240条页码: 1/24页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分